Emerg Infect DisEmerging Infect. DisEIDEmerging Infectious Diseases1080-60401080-6059Centers for Disease Control and Prevention21801641338157410-080010.3201/eid1708.100800DispatchImported Measles and Implications for Its Elimination in Taiwan Running head: Imported Measles, Taiwan, 2009ChengWen-YuehYangChen-FuHouYu-TingWangShih-ChuanChangHsiu-LiChiuHsien-YaWangEn-TzuWuHo-ShengAuthor affiliation: Centers for Disease Control, Taipei, TaiwanAddress for correspondence: Wen-Yueh Cheng, Centers for Disease Control, 161 Kun-Yang St, Nan-Kang District, Taipei, Taiwan 11561; email: yueh@cdc.gov.tw8201117815231526

During November 2008–May 2009, an outbreak of 53 measles cases occurred in Taiwan. Of these, 3 cases were sporadic, and the other 50 cases could be grouped into 8 clusters by genetic analysis. We determined 7 H1 genotypes linked to importation and 1 G3 genotype linked to an untraceable source.

Keywords: virusesmeaslesTaiwannosocomialmeasles outbreakimportationdispatch

The availability of a measles vaccine in the 1960s led to substantial reductions in the incidence of measles globally. Along with improvements in living conditions, nutrition, and the availability of antimicrobial drugs for secondary bacterial infections, the mortality rate was greatly reduced (1). A live-attenuated measles vaccine was introduced to Taiwan in 1968, and a routine vaccination policy was established in 1978 to provide measles vaccine to infants at 9 and 15 months of age. During 1992–1994 and 2001–2004, two catch-up campaigns were implemented, targeting birth cohorts September 1976 to September 1990 and September 1990 to September 1994, respectively. Starting in 2006, the measles, mumps, and rubella (MMR) vaccine targeted infants 12–15 months old and 6-year-old children. The coverage rates for the first dose of measles vaccine and the second dose of MMR were 91% and 95%, respectively, since 1996. In recent decades in Taiwan, 4 major measles outbreaks have occurred, with 2,219 (in 1985), 1,386 (1988), 1,060 (1989), and 303 (1992) reported cases. Beginning in 1993, the annual number of reported measles cases was <100; by the end of 2007, the annual number of confirmed measles cases was <10 (2). The ability to actively control measles has increased in Taiwan since 1991 because of a combined plan to eliminate polio, measles, congenital rubella syndrome and neonatal tetanus.

The key to controlling measles is achieving and sustaining high levels of vaccination coverage. Finding a way to prevent the transmission of measles is an important topic for any country in the elimination phase. Here, we report several measles outbreaks that occurred in Taiwan during 2008 and 2009.

The Study

In total, 140 suspected measles cases were reported to the Taiwan Centers for Disease Control from November 2008 to May 2009, and 53 were confirmed (Table A1). The criteria for confirming cases included laboratory diagnosis and establishing an epidemiologic link to the laboratory-diagnosed case. The criteria for the laboratory diagnosis included the presence of measles immunoglobulin (Ig) M, isolation of measles virus, or identification of measles virus by reverse transcription PCR (2,3).

A timetable for occurrence of the 53 measles cases was constructed (Figure 1, panel A) on the basis of the week of onset of rash for each patient. The locations of the hospitals that reported these cases are shown in Figure 1, panel B.

A) Timetable of 53 measles cases reported in Taiwan from week 45 of 2008 to week 21 of 2009. Each cell in the timetable represents 1 case; each case is identified with an identification number followed by a letter that represents the hospital (uppercase) or clinic (lowercase) that reported the case. Cases 1–8, 9–21, 22–24, 25–33, 34–35, 36–45, 46–48, and 49–50 belong to clusters 1 through 8, respectively, and cells within a cluster are the same color. Cases 51–53 were from 3 sporadic cases and are not colored. The case numbers peaked during the eighth week of 2009, with 8 cases distributed through northern (hospital D), central (hospital E), and southern (hospitals F and P) Taiwan; these cases originated from 4 importation chains. B) Locations of hospitals involved in measles outbreaks. *Hospital was involved in nosocomial transmission.

Cluster 1 involved nosocomial infections in hospital A (case-patients 1–5) and hospital B (case-patients 6–8); the transmission between case-patient 5 and case-patient 6 was through household contact. The index case-patient (case 7) was discovered later. Cluster 2 (case-patients 9–21) caused nosocomial infections in hospitals C (case-patients 9–10) and D (case-patients 10–17 and 19). Case-patient 18 was reported by hospital F, case-patient 20 from clinic b and case-patient 21 from hospital O. With the exception of case-patient 20, who attended kindergarten with case-patient 19, there was no exposure linkage between case-patients 18 and 21; the phylogenic data (Figure 2) did, however, indicate the patients were infected with related strains. Cluster 3 involved case-patients 22–24; the index case-patient was the source of transmission and caused the nosocomial infection in hospital E. Cluster 4 (case-patients 25–33) caused nosocomial infections in hospital F (case-patients 25 and 27–33), and case-patients 25 and 26 attended the same school. Cluster 5 (case-patients 34–35) was a nosocomial infection in hospital G. Cluster 6 involved 10 cases: the index case-patient, case 37, was reported by hospital I. Case-patients 36–43 were from the same military base, and case-patients 37, 44, and 45 were relatives. Cluster 7 caused nosocomial infections in hospital H (case-patients 46 and 47) as well as household transmissions (case-patients 47 and 48). Cluster 8 (case-patients 49 and 50) was transmitted by contact at a dormitory. Case-patient 51 had a sporadic case from an unidentified source; case-patients 52 and 53 had sporadic cases linked to importation from Vietnam and India, respectively.

Phylogenetic analyses of the 456 carboxyl-terminal nucleotides of the N gene sequences of isolates obtained from 45 measles case-patients from November 2008 through May 2009, Taiwan. The respective accession number for each sequence is shown in parentheses following the strain name. Boldface italics indicate World Health Organization reference strains. The unrooted neighbor-joining consensus tree was generated by bootstrap analysis of 1,000 replicates by using MEGA4 software (www.megasoftware.net). Scale bar indicates nucleotide substitutions per site.

Of these 53 patients with confirmed measles, 36 (67.9%) were male. There were 15 children (28.3%) <12 months of age and 19 children (35.8%) from 12 months to 6 years of age. Adults accounted for 19 cases (35.8%). Only 1 patient (1.88%) had received 2 doses of a measles-containing vaccine; 4 patients (7.5%) had received 1 dose; 7 patients (13.2%) recalled having received vaccines; 9 adults (17.0%) did not know their vaccination status; and the remaining 31 patients (58.4%) had not received any vaccines. Among the 6 nosocomial measles outbreaks, 2 infection sources (clusters 2 and 5) were children <12 months old and therefore not eligible for the first dose of the MMR vaccine, 4 clusters (clusters 1, 3, 4, and 7) were caused by children between 13–17 months old who were not vaccinated, and 1 cluster (cluster 8) was caused by an adult from Vietnam with an uncertain vaccination history. The outbreak on the military base was caused by an adult who was assumed to have been vaccinated.

Phylogenic analysis determined that the measles virus genotypes from these 8 outbreaks fell into 6 clades (Figure 2). Although the source was untraceable, the measles virus sequences from cluster 6 belonged to genotype G3; the sequence was 100% identical to a G3 strain (MVi/H Kajang.MYS/11.09) isolated from Malaysia (T. Tran, pers. comm.). The other sequences all belonged to genotype H1 and were grouped into 5 lineages. Clusters 1, 2, and 3 were linked to importation from the People’s Republic of China and were grouped into different lineages. Clusters 4, 5, 7, and 8, which originated in Vietnam, were divided into 2 lineages, with clusters 4, 7, and 8 in the same lineage and cluster 5 in another lineage.

Conclusions

Among these 53 confirmed cases, 26 (49%) patients contracted measles from hospital exposure, and 3 patients (5.7%) were hospital staff. Vaccination policies for workers in health care institutes should be strengthened because these workers have the highest potential risk of contracting the disease (4,5). Many other febrile exanthematic diseases caused by pathogens other than measles virus, such as enterovirus, rubella virus, parvovirus B19, human herpesvirus-6, or Kawasaki syndrome, could have symptoms similar to measles and be misdiagnosed (68). It is therefore vital to ensure that clinicians are fully aware of the disease and can recognize it in a timely manner.

After import-associated measles outbreaks were recognized, the MMR vaccination was recommended for persons planning to travel to measles-endemic countries. Successful immunization policies that include routinely vaccinating children with 2 doses of a measles-containing vaccine greatly reduce disease contraction among preschool and primary school children (911). Because measles outbreaks may occur in areas with high vaccine coverage (1214), the higher proportion of measles cases in adults, especially in young adults, should be addressed further and evaluated with regard to the possible need for additional immunizations.

The major threats to measles control in Taiwan are similar to those faced by other countries in the elimination phase; the key questions are 1) how to detect the index case in real time, and 2) how to prevent import-associated transmission. Among these continuous outbreaks, 6 chains originated from children <18 months of age without adequate immunization who had recently traveled to measles-endemic countries. Clinicians being alert for patients being brought for treatment with a fever and rash at pediatric clinics will greatly improve the sensitivity of measles surveillance systems and prevent further nosocomial transmission. Special emphasis should be paid to pediatric patients without vaccination records and with a history of travel abroad. Of course, the ultimate goal of eliminating measles requires an agreement from all countries to contain the disease in their own territories.

Suggested citation for this article: Cheng W-Y, Yang C-F, Hou Y-T, Wang S-C, Chang H-L, Chiu H-Y, et al. Imported measles and implications for its elimination in Taiwan. Emerg Infect Dis [serial on the Internet]. 2011 Aug [date cited]. http://dx.doi.org/10.3201/eid1708.100800

Acknowledgments

We thank Chan-Hsien Chiu, Tsui-Feng Li, Yi-Chun Wu, Li-Jen Lin, and Ding-Pin Liu for their support and guidance.

This work was supported by the Centers for Disease Control, Taiwan.

Characteristics of 53 measles case-patients in outbreaks in Taiwan, November 2008–May 2009*
Classification
(year) and case no.Patient sexPatient age, y/moDate of rash onsetDate of samplingVaccination‡GenotypeStrain§Immunoglobulin¶
MG
Cluster 1 (2008)
1F01/05Nov 4Nov 6NoH1MVs/Kaohsiung.TWN/45.08NDND
2M00/11Nov 15Jan 22†NoEP
3F04/05Nov 17Nov 21NoH1MVs/Kaohsiung.TWN/47.08PP
4F00/09Nov 20Jan 22†NoEP
5M02/05Dec 2Jan 17†NoPP
6M02/05Dec 13Dec 16NoPP
7M00/09Dec 23Dec 26NoH1MVs/Kaohsiung.TWN/52.08PN
8
F
39/11
Dec 29
Dec 31
No
H1
MVi/Kaohsiung.TWN/53.08
P
P
Cluster 2 (2009)
9F00/11Jan 27Jan 28NoMVs/Tainan.TWN/05.09PP
10M05/05Feb 9Feb 11YesH1MVi/Taoyuan.TWN/07.09PN
11F02/01Feb 17Feb 22NoH1MVi/Taoyuan.TWN/09.09/2PN
12M00/09Feb 18Feb 22NoH1MVi/Taoyuan.TWN/09.09/3PN
13M01/06Feb 21Feb 22NoH1MVs/Taoyuan.TWN/09.09/4PN
14M00/10Feb 21Feb 22NoH1MVi/Taoyuan.TWN/09.09/5PN
15M00/10Feb 22Feb 22NoH1MVi/Taoyuan.TWN/09.09/1PN
16M00/10Feb 22Feb 23NoH1MVi/Taoyuan.TWN/09.09/6NN
Mar 3PP
17F02/05Feb 24Feb 24NoH1MVs/Taoyuan.TWN/09.09/7PN
18F39/10Feb 23Feb 26UnknownH1MVi/Tainan.TWN/09.09/9PE
19M05/05Mar 4Mar 10YesH1MVs/Taipei.TWN/11.09/1PE
20F06/03Mar 15Mar 18Yes (2 doses)PP
21
M
03/02
Apr 2
Apr 14
No
H1
MVi/Taipei.TWN/16.09/2
P
N
Cluster 3 (2009)
22M01/04Feb 6Feb 20YesH1MVs/Taichung.TWN/08.09PN
23F01/04Feb 20Feb 25NoH1MVs/Taichung.TWN/09.09/8PN
24
M
00/09
Feb 17
Feb 26
No
H1
MVs/Taichung.TWN/09.09/10
P
P
Cluster 4 (2009)
25F01/01Feb 15Mar 3NoPP
26M02/03Feb 17Feb 26NoH1MVs/Tainan.TWN/09.09/11PN
27M31/11Feb 24Feb 28YesH1MVi/Taoyuan.TWN/09.09/12PN
28M00/08Feb 27Mar 2NoH1MVs/Tainan.TWN/10.09/2PN
29M29/06Feb 28Mar 1YesH1MVs/Tainan.TWN/10.09/1NP
Mar 16PP
30F00/11Mar 1Mar 4NoH1MVi/Tainan.TWN/10.09/3PN
31F36/04Mar 8Mar 10UnknownH1MVs/Tainan.TWN/11.09/2PP
32M23/07Mar 13Mar 13YesH1MVs/Tainan.TWN/11.09/4NP
33
M
26/06
Mar 13
Mar 13Unknown
H1
MVi/Tainan.TWN/11.09/5
NN
Mar 19
P
P
Cluster 5 (2009)
34M00/11Mar 6Mar 11NoH1MVs/Taipei.TWN/11.09/3PP
35
M
01/01
Mar 20
Mar 24
Yes
H1
MVi/Taipei.TWN/13.09
P
N
Cluster 6 (2009)
36M19/09Mar 27Apr 15YesG3MVs/Pingtung.TWN/16.09/4PP
37M21/11Apr 7Apr 9YesG3MVi/Kaohsiung.TWN/15.09/1PN
38M20/02Apr 8Apr 11UnknownG3MVi/Kaohsiung.TWN/15.09/2PP
39M19/06Apr 8Apr 11YesG3MVs/Kaohsiung.TWN/15.09/3PP
40M23/04Apr 9Apr 11YesG3MVs/Kaohsiung.TWN/15.09/4NP
41M25/07Apr 6Apr 13UnknownG3MVs/Kaohsiung.TWN/16.09/1PP
42M22/10Apr 12Apr 14YesG3MVs/Kaohsiung.TWN/16.09/3NP
43M21/00Apr 12Apr 15UnknownG3MVs/Kaohsiung.TWN/16.09/5PP
44M21/04Apr 14Apr 20UnknownG3MVi/Kaohsiung.TWN/17.09/2PN
45
F
00/05
Apr 20
Apr 22
No
G3
MVi/Kaohsiung.TWN/17.09/3
P
N
Cluster 7 (2009)
46M01/02Apr 14Apr 27NoH1PP
47M38/08Apr 26May 12UnknownH1MVs/Taichung.TWN/20.09PP
48
M
00/08
May 3
May 6
No
H1
MVi/Taichung.TWN/19.09/2
P
N
Cluster 8 (2009)
49M22/06Apr 17Apr 20UnknownH1MVi/Taoyuan.TWN/17.09/1PP
50
M
33/00
Apr 30
Apr 30
Yes
H1
MVi/Taoyuan.TWN/19.09/1
N
P
Sporadic
51F01/03Feb 16Feb 19YesPP
52F03/11Mar 08Mar 09YesH1MVi/Taichung.TWN/11.09/6PE
53F00/11May 23May 25NoD8MVs/Taipei.TWN/22.09PN

*The index case number for each cluster is denoted by boldface and underlining. – indicates PCR failed to obtain correspondence sequence for genetic analysis. Patients 16 and 29 provided samples twice.
†The sampling year was 2009.
‡ Boldface indicates that these patients received the measles, mumps, rubella (MMR) vaccine within 2 weeks of rash onset. Italic indicates that the vaccination status was from patient or parent recall.
§The strains were deposited into GenBank under accession numbers. GQ338677–GQ338680, HM072047–HM072085, and JF683608–JF683609
¶ND, not done; N, negative; P, positive; and E, equivocal.

Ms Cheng is an associate researcher at Centers for Disease Control Taiwan. She is in charge of laboratory diagnosis of measles, rubella, mumps, and varicella-zoster virus infection. Her research interests involve the changing epidemiology of vaccine-preventable diseases.

ReferencesMoss WJ. Measles control and the prospect of eradication. Curr Top Microbiol Immunol. 2009;330:17389 10.1007/978-3-540-70617-5_919203110Cheng WY, Lee L, Rota PA, Yang DC. Molecular evolution of measles viruses circulated in Taiwan 1992–2008. Virol J. 2009;6:219 10.1186/1743-422X-6-21920003242World Health Organization. Manual for the laboratory diagnosis of measles and rubella virus infection. 2nd ed. Geneva; The Organization; 2007Krause PJ, Gross PA, Barrett TL, Dellinger EP, Martone WJ, McGowan JE Jr, Quality standard for assurance of measles immunity among health care workers. Infectious Diseases Society of America. Clin Infect Dis. 1994;18:4316 10.1093/clinids/18.3.4318011829Mendelson GM, Roth CE, Wreghitt TG, Brown NM, Ziegler E, Lever AM. Nosocomial transmission of measles to healthcare workers. Time for a national screening and immunization policy for NHS staff? J Hosp Infect. 2000;44:1545 10.1053/jhin.1999.066710662570Davidkin I, Valle M, Peltola H, Hovi T, Paunio M, Roivainen M, Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. J Infect Dis. 1998;178:156770 10.1086/3145139815205Oliveira SA, Turner DJ, Knowles W, Nascimento JP, Brown DW, Ward KN. Primary human herpesvirus-6 and -7 infections, often coinciding, misdiagnosed as measles in children from a tropical region of Brazil. Epidemiol Infect. 2003;131:8739 10.1017/S095026880300882314596528Ramsay M, Reacher M, O'Flynn C, Buttery R, Hadden F, Cohen B, Causes of morbilliform rash in a highly immunised English population. Arch Dis Child. 2002;87:2026 10.1136/adc.87.3.20212193426Domínguez A, Torner N, Barrabeig I, Rovira A, Rius C, Cayla J, Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule. Clin Infect Dis. 2008;47:11439 10.1086/59225818823269Muscat M, Christiansen AH, Persson K, Plesner AM, Bottiger BE, Glismann S, Measles outbreak in the Øresund region of Denmark and Sweden. Euro Surveill. 2006;11(3):E060330.4.Parker AA, Staggs W, Dayan GH, Ortega-Sanchez IR, Rota PA, Lowe L, Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med. 2006;355:44755 10.1056/NEJMoa06077516885548Edmonson MB, Addiss DG, McPherson JT, Berg JL, Circo SR, Davis JP. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA. 1990;263:246771 10.1001/jama.263.18.24672278542Ong G, Rasidah N, Wan S, Cutter J. Outbreak of measles in primary school students with high first dose MMR vaccination coverage. Singapore Med J. 2007;48:6566117609829Yeung LF, Lurie P, Dayan G, Eduardo E, Britz PH, Redd SB, A limited measles outbreak in a highly vaccinated US boarding school. Pediatrics. 2005;116:128791 10.1542/peds.2004-271816322148